STOCK TITAN

Venus Concept to Release Third Quarter of Fiscal Year 2023 Financial Results on November 14, 2023

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Venus Concept Inc. to release Q3 financial results on November 14, 2023
Positive
  • Venus Concept Inc. will release its third quarter financial results on November 14, 2023.
  • The Company is a global medical aesthetic technology leader.
Negative
  • None.

TORONTO, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2023 financial results will be released after the market closes on Tuesday, November 14, 2023.

Management will host a conference call at 5:00 p.m. Eastern Time on November 14, 2023 to discuss the results of the quarter with a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13741931. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.

For those unable to participate, a replay of the call will be available for two weeks at: 877-660-6853 (201-612-7415 for international callers); access code 13741934. The webcast will be archived at ir.venusconcept.com.

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 14 direct markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve, Venus Viva MD and AI.ME. Venus Concept’s hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations.


FAQ

When will Venus Concept Inc. release its Q3 financial results?

Venus Concept Inc. will release its Q3 financial results on November 14, 2023.

What is Venus Concept Inc.'s stock symbol?

Venus Concept Inc.'s stock symbol is VERO.

What is Venus Concept Inc.'s industry?

Venus Concept Inc. is a global medical aesthetic technology leader.

How can I participate in the conference call?

To participate in the conference call, dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13741931.

Where can I find the webcast of the call?

The webcast of the call will be provided on the investor relations section of the Company's website at ir.venusconcept.com.

Will there be a replay of the call?

Yes, a replay of the call will be available for two weeks. Dial 877-660-6853 (201-612-7415 for international callers) and provide access code 13741934 to access the replay.

Where can I find the archived webcast?

The archived webcast will be available at ir.venusconcept.com.

Venus Concept Inc.

NASDAQ:VERO

VERO Rankings

VERO Latest News

VERO Stock Data

4.24M
2.57M
8.02%
47.85%
0.44%
Surgical Appliance and Supplies Manufacturing
Manufacturing
Link
United States of America
TORONTO

About VERO

venus concept is a leader in the global medical aesthetic market, pairing best-in-class technology with the first and only true subscription model in the industry. our goal is to help both new and established practices succeed in this growing field. we understand the challenges of breaking into and being successful in the aesthetics industry, and that’s why we’re changing the game with an innovative solution. the secret is in our industry-unique subscription model. in partnering with venus concept, aesthetic professionals worldwide gain access to never-before-seen business features such as the most comprehensive warranty program, unmatched marketing support, continuous clinical education, valuable practice enhancement programs, and more. together with this business model, our collection of aesthetic systems—including venus versa™, venus legacy™, venus velocity™, venus viva™, venus freeze plus™, and venus skin™—are setting higher industry standards and improving the quality of life for